Beta
Back to 4164.TW Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
revenue-chart

4164 Revenue

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

default symbol

4164

承業醫

29.05D

-1.38%

(-0.01)

承業醫 (4164.TW) 2025Q4 financial report shows revenue of 1.21B TWD, with a YoY growth rate of 18.40%. This data clearly demonstrates significant revenue growth, with the company showing strong operational momentum and a marked increase in market demand. To fully capture future growth potential and investment opportunities, investors should closely monitor 承業醫 (4164.TW)’s upcoming financial reports and key strategic adjustments, and leverage diversified data analysis, especially advanced tools like Growin AI Value Analysis, for a comprehensive and forward-looking evaluation.